FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3026639275> ?p ?o ?g. }

• W3026639275 endingPage "110246" @default.
• W3026639275 startingPage "110246" @default.
• W3026639275 abstract "Dysregulated microRNAs (miRNAs/miRs) directly modulate the biological functions of gastric cancer (GC) cells and contribute to the initiation and progression of GC. MiR-17-5p and runt-related transcription factor 3 (RUNX3) have been reported to be related to GC progression; however, the specific interaction between miR-17-5p and RUNX3 in GC require further investigation. Western blotting, real-time PCR and immunohistochemistry were used to study the expression level of miR-17-5p and RUNX3 in gastric cancer tissues and plasma. The biological function of miR-17-5p was examined by measuring cell proliferation, apoptosis and cell invasion in vitro; the target gene of miR17-5p was identified by luciferase reporter assays, RNA Binding protein immunoprecipitation (RIP) and western blotting. In vivo animal study was conducted to confirm the role of miR-17-5p during tumorigensis of gastric cancer. This study showed that miR17-5p was upregulated in the plasma and tissues of patients with GC, while RUNX3 was downregulated in GC tissues. Functional experiments indicated that miR-17-5p mimics promoted the proliferation and invasion of GC via suppressing apoptosis in vitro. Furthermore, bioinformatics prediction, luciferase reporter assays, reverse transcription quantitative polymerase chain reaction assays, RIP and western blotting analysis demonstrated that RUNX3 was a direct target gene of miR-17-5p in GC. In addition, overexpression of RUNX3 suppressed the proliferation and invasiveness of GC cells. In vivo data indicated miR-17-5p agomir significantly promoted tumor growth. In contrast, miR-17-5p antagomir notably decreased tumor volume compared with control group. MiR-17-5p promoted the progression of GC via directly targeting RUNX3, suggesting that miR-17-5p and RUNX3 could be considered as diagnostic and therapeutic targets for patients with GC." @default.
• W3026639275 created "2020-05-29" @default.
• W3026639275 creator A5017687729 @default.
• W3026639275 creator A5021166268 @default.
• W3026639275 creator A5030600214 @default.
• W3026639275 creator A5069228108 @default.
• W3026639275 creator A5071168196 @default.
• W3026639275 date "2020-08-01" @default.
• W3026639275 modified "2023-10-11" @default.
• W3026639275 title "MiR-17-5p promotes cellular proliferation and invasiveness by targeting RUNX3 in gastric cancer" @default.
• W3026639275 cites W1982298464 @default.
• W3026639275 cites W1993799748 @default.
• W3026639275 cites W1998153888 @default.
• W3026639275 cites W2001574956 @default.
• W3026639275 cites W2009014150 @default.
• W3026639275 cites W2010241362 @default.
• W3026639275 cites W2010932574 @default.
• W3026639275 cites W2041809728 @default.
• W3026639275 cites W2048662026 @default.
• W3026639275 cites W2051578118 @default.
• W3026639275 cites W2084034527 @default.
• W3026639275 cites W2097655831 @default.
• W3026639275 cites W2106787323 @default.
• W3026639275 cites W2108836814 @default.
• W3026639275 cites W2121787561 @default.
• W3026639275 cites W2146937880 @default.
• W3026639275 cites W2150849546 @default.
• W3026639275 cites W2162344448 @default.
• W3026639275 cites W2170295391 @default.
• W3026639275 cites W2170552969 @default.
• W3026639275 cites W2340375312 @default.
• W3026639275 cites W2345599867 @default.
• W3026639275 cites W2480182873 @default.
• W3026639275 cites W2513990735 @default.
• W3026639275 cites W2624111147 @default.
• W3026639275 cites W2736853655 @default.
• W3026639275 cites W2767755050 @default.
• W3026639275 cites W2800850565 @default.
• W3026639275 cites W2896829986 @default.
• W3026639275 cites W2912844993 @default.
• W3026639275 cites W2917837889 @default.
• W3026639275 cites W2922330597 @default.
• W3026639275 doi "https://doi.org/10.1016/j.biopha.2020.110246" @default.
• W3026639275 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32447210" @default.
• W3026639275 hasPublicationYear "2020" @default.
• W3026639275 type Work @default.
• W3026639275 sameAs 3026639275 @default.
• W3026639275 citedByCount "33" @default.
• W3026639275 countsByYear W30266392752021 @default.
• W3026639275 countsByYear W30266392752022 @default.
• W3026639275 countsByYear W30266392752023 @default.
• W3026639275 crossrefType "journal-article" @default.
• W3026639275 hasAuthorship W3026639275A5017687729 @default.
• W3026639275 hasAuthorship W3026639275A5021166268 @default.
• W3026639275 hasAuthorship W3026639275A5030600214 @default.
• W3026639275 hasAuthorship W3026639275A5069228108 @default.
• W3026639275 hasAuthorship W3026639275A5071168196 @default.
• W3026639275 hasBestOaLocation W30266392751 @default.
• W3026639275 hasConcept C104317684 @default.
• W3026639275 hasConcept C105580179 @default.
• W3026639275 hasConcept C121608353 @default.
• W3026639275 hasConcept C127561419 @default.
• W3026639275 hasConcept C145059251 @default.
• W3026639275 hasConcept C150903083 @default.
• W3026639275 hasConcept C153911025 @default.
• W3026639275 hasConcept C190283241 @default.
• W3026639275 hasConcept C207001950 @default.
• W3026639275 hasConcept C4692481 @default.
• W3026639275 hasConcept C502942594 @default.
• W3026639275 hasConcept C54355233 @default.
• W3026639275 hasConcept C55493867 @default.
• W3026639275 hasConcept C62112901 @default.
• W3026639275 hasConcept C85265743 @default.
• W3026639275 hasConcept C86803240 @default.
• W3026639275 hasConceptScore W3026639275C104317684 @default.
• W3026639275 hasConceptScore W3026639275C105580179 @default.
• W3026639275 hasConceptScore W3026639275C121608353 @default.
• W3026639275 hasConceptScore W3026639275C127561419 @default.
• W3026639275 hasConceptScore W3026639275C145059251 @default.
• W3026639275 hasConceptScore W3026639275C150903083 @default.
• W3026639275 hasConceptScore W3026639275C153911025 @default.
• W3026639275 hasConceptScore W3026639275C190283241 @default.
• W3026639275 hasConceptScore W3026639275C207001950 @default.
• W3026639275 hasConceptScore W3026639275C4692481 @default.
• W3026639275 hasConceptScore W3026639275C502942594 @default.
• W3026639275 hasConceptScore W3026639275C54355233 @default.
• W3026639275 hasConceptScore W3026639275C55493867 @default.
• W3026639275 hasConceptScore W3026639275C62112901 @default.
• W3026639275 hasConceptScore W3026639275C85265743 @default.
• W3026639275 hasConceptScore W3026639275C86803240 @default.
• W3026639275 hasFunder F4320321001 @default.
• W3026639275 hasLocation W30266392751 @default.
• W3026639275 hasOpenAccess W3026639275 @default.
• W3026639275 hasPrimaryLocation W30266392751 @default.
• W3026639275 hasRelatedWork W2026862129 @default.
• W3026639275 hasRelatedWork W2080599553 @default.
• W3026639275 hasRelatedWork W2466886203 @default.
• W3026639275 hasRelatedWork W2592007767 @default.

• next